BlackRock Investment Management’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$37.1M Buy
316,280
+52,958
+20% +$6.04M 0.04% 374
2016
Q3
$29.7M Sell
263,322
-2,197
-0.8% -$232K 0.04% 412
2016
Q2
$24.7M Buy
265,519
+14,455
+6% +$1.24M 0.03% 478
2016
Q1
$19.7M Sell
251,064
-8,872
-3% -$639K 0.03% 587
2015
Q4
$19M Sell
259,936
-1,778
-0.7% -$127K 0.02% 601
2015
Q3
$19.4M Sell
261,714
-9,640
-4% -$690K 0.03% 566
2015
Q2
$17.4M Buy
271,354
+14,418
+6% +$998K 0.02% 647
2015
Q1
$19.8M Sell
256,936
-1,830
-0.7% -$142K 0.03% 572
2014
Q4
$19.2M Sell
258,766
-17,470
-6% -$1.23M 0.03% 570
2014
Q3
$16.3M Sell
276,236
-4,678
-2% -$296K 0.02% 621
2014
Q2
$18.8M Sell
280,914
-5,884
-2% -$374K 0.03% 577
2014
Q1
$17.4M Sell
286,798
-5,300
-2% -$316K 0.03% 583
2013
Q4
$15.5M Sell
292,098
-5,996
-2% -$316K 0.02% 620
2013
Q3
$14.9M Buy
298,094
+21,228
+8% +$1.02M 0.02% 598
2013
Q2
$12.4M Buy
+276,866
New +$12.1M 0.02% 640

Other funds holding IDXX

BlackRock Investment Management's IDXX Position: Q4 2016 in Review

BlackRock Investment Management increased its Idexx Laboratories (IDXX) stake by 20% in Q4 2016, buying an estimated $6.04M and bringing the position to 316,280 shares worth $37.1M. The position accounts for 0.04% of the portfolio, ranked #374.

BlackRock Investment Management first reported a position in IDXX in Q2 2013 and has held it in 15 quarters since. 522 funds tracked by Wall St. Rank hold IDXX as of Q4 2016.

  • BlackRock Investment Management held 316,280 shares of Idexx Laboratories worth $37.1M as of Q4 2016.
  • BlackRock Investment Management bought 52,958 Idexx Laboratories shares in Q4 2016, an estimated $6.04M.
  • Idexx Laboratories made up 0.04% of BlackRock Investment Management's portfolio in Q4 2016, its #374 holding.
  • BlackRock Investment Management first reported a position in Idexx Laboratories in Q2 2013 and has held it in 15 quarters since.
  • 522 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.